Pharmacokinetic properties of a single intramuscular dose of buprenorphine in African grey parrots (Psittacus erithacus erithacus)

Joanne R Paul-Murphy, Jennifer C. Hess, James P. Fialkowski

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Buprenorphine is a synthetic mixed agonist-antagonist opiate analgesic that is used in a variety of species. To determine if a dose of buprenorphine at 0.1 mg/kg achieves plasma concentrations in parrots that would be analgesic in humans (0.5-1.0 ng/ml), we administered a single dose of buprenorphine (at 0.1 mg/kg) either intramuscularly (5 birds) or intravenously (1 bird) to African grey parrots (Psittacus erithacus erithacus). Serial plasma samples were taken before and at 0.25, 0.5, 0.75, 1.0, 1.5, 2, 6, and 8 hours after administration. For a single intramuscular dose, buprenorphine was rapidly absorbed, and plasma concentrations had a mean residence time of 1.0 hour, elimination half-life of 1.0 hour, and maximum concentration of 68.7 ng/ml, determined by using noncompartmental analysis. This dose of buprenorphine can achieve plasma levels for at least 2 hours in the African grey parrot for comparable analgesic levels in humans, however buprenorphine is not recommended as an analgesic treatment for parrots until pharmacokinetic and analgesia studies are done at higher doses.

Original languageEnglish (US)
Pages (from-to)224-228
Number of pages5
JournalJournal of Avian Medicine and Surgery
Volume18
Issue number4
StatePublished - Dec 2004
Externally publishedYes

Fingerprint

Parrots
buprenorphine
Buprenorphine
pharmacokinetics
Pharmacokinetics
analgesics
Analgesics
dosage
parrots
Birds
Opiate Alkaloids
birds
analgesia
Analgesia
agonists
half life
Half-Life
Psittacus erithacus
antagonists

Keywords

  • African grey parrot
  • Analgesia
  • Avian
  • Buprenorphine
  • Noncompartmental pharmacokinetics
  • Opioid
  • Psittacus erithacus

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Pharmacokinetic properties of a single intramuscular dose of buprenorphine in African grey parrots (Psittacus erithacus erithacus). / Paul-Murphy, Joanne R; Hess, Jennifer C.; Fialkowski, James P.

In: Journal of Avian Medicine and Surgery, Vol. 18, No. 4, 12.2004, p. 224-228.

Research output: Contribution to journalArticle

@article{8056fd46416141aea695b7bb37532586,
title = "Pharmacokinetic properties of a single intramuscular dose of buprenorphine in African grey parrots (Psittacus erithacus erithacus)",
abstract = "Buprenorphine is a synthetic mixed agonist-antagonist opiate analgesic that is used in a variety of species. To determine if a dose of buprenorphine at 0.1 mg/kg achieves plasma concentrations in parrots that would be analgesic in humans (0.5-1.0 ng/ml), we administered a single dose of buprenorphine (at 0.1 mg/kg) either intramuscularly (5 birds) or intravenously (1 bird) to African grey parrots (Psittacus erithacus erithacus). Serial plasma samples were taken before and at 0.25, 0.5, 0.75, 1.0, 1.5, 2, 6, and 8 hours after administration. For a single intramuscular dose, buprenorphine was rapidly absorbed, and plasma concentrations had a mean residence time of 1.0 hour, elimination half-life of 1.0 hour, and maximum concentration of 68.7 ng/ml, determined by using noncompartmental analysis. This dose of buprenorphine can achieve plasma levels for at least 2 hours in the African grey parrot for comparable analgesic levels in humans, however buprenorphine is not recommended as an analgesic treatment for parrots until pharmacokinetic and analgesia studies are done at higher doses.",
keywords = "African grey parrot, Analgesia, Avian, Buprenorphine, Noncompartmental pharmacokinetics, Opioid, Psittacus erithacus",
author = "Paul-Murphy, {Joanne R} and Hess, {Jennifer C.} and Fialkowski, {James P.}",
year = "2004",
month = "12",
language = "English (US)",
volume = "18",
pages = "224--228",
journal = "Journal of Avian Medicine and Surgery",
issn = "1082-6742",
publisher = "Association of Avian Veterinarians",
number = "4",

}

TY - JOUR

T1 - Pharmacokinetic properties of a single intramuscular dose of buprenorphine in African grey parrots (Psittacus erithacus erithacus)

AU - Paul-Murphy, Joanne R

AU - Hess, Jennifer C.

AU - Fialkowski, James P.

PY - 2004/12

Y1 - 2004/12

N2 - Buprenorphine is a synthetic mixed agonist-antagonist opiate analgesic that is used in a variety of species. To determine if a dose of buprenorphine at 0.1 mg/kg achieves plasma concentrations in parrots that would be analgesic in humans (0.5-1.0 ng/ml), we administered a single dose of buprenorphine (at 0.1 mg/kg) either intramuscularly (5 birds) or intravenously (1 bird) to African grey parrots (Psittacus erithacus erithacus). Serial plasma samples were taken before and at 0.25, 0.5, 0.75, 1.0, 1.5, 2, 6, and 8 hours after administration. For a single intramuscular dose, buprenorphine was rapidly absorbed, and plasma concentrations had a mean residence time of 1.0 hour, elimination half-life of 1.0 hour, and maximum concentration of 68.7 ng/ml, determined by using noncompartmental analysis. This dose of buprenorphine can achieve plasma levels for at least 2 hours in the African grey parrot for comparable analgesic levels in humans, however buprenorphine is not recommended as an analgesic treatment for parrots until pharmacokinetic and analgesia studies are done at higher doses.

AB - Buprenorphine is a synthetic mixed agonist-antagonist opiate analgesic that is used in a variety of species. To determine if a dose of buprenorphine at 0.1 mg/kg achieves plasma concentrations in parrots that would be analgesic in humans (0.5-1.0 ng/ml), we administered a single dose of buprenorphine (at 0.1 mg/kg) either intramuscularly (5 birds) or intravenously (1 bird) to African grey parrots (Psittacus erithacus erithacus). Serial plasma samples were taken before and at 0.25, 0.5, 0.75, 1.0, 1.5, 2, 6, and 8 hours after administration. For a single intramuscular dose, buprenorphine was rapidly absorbed, and plasma concentrations had a mean residence time of 1.0 hour, elimination half-life of 1.0 hour, and maximum concentration of 68.7 ng/ml, determined by using noncompartmental analysis. This dose of buprenorphine can achieve plasma levels for at least 2 hours in the African grey parrot for comparable analgesic levels in humans, however buprenorphine is not recommended as an analgesic treatment for parrots until pharmacokinetic and analgesia studies are done at higher doses.

KW - African grey parrot

KW - Analgesia

KW - Avian

KW - Buprenorphine

KW - Noncompartmental pharmacokinetics

KW - Opioid

KW - Psittacus erithacus

UR - http://www.scopus.com/inward/record.url?scp=10344248246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10344248246&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:10344248246

VL - 18

SP - 224

EP - 228

JO - Journal of Avian Medicine and Surgery

JF - Journal of Avian Medicine and Surgery

SN - 1082-6742

IS - 4

ER -